Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.41.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-14517.8Singapore
GS.4.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-14335.1Singapore
JF.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JG.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBBSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.62SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FU.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBL.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.24.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.9.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FE.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FR.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FU.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GJ.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.22.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FE.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBL.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.56SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.568SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.13 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.372SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.634SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
C.37.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.630SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.360SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.578SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.544SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.448SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.425SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.354SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.503SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.623SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.214.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.588SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used